Visceral pseudoaneurysm is a rare but well-described complication of pancreatitis 1,2 caused by the autodigestive function of pancreatic enzymes. 3 The splenic, gastroduodenal, pancreaticoduodenal, and hepatic arteries are most commonly affected. 2, 4 Pseudoaneurysms require active management because of the high complication and mortality rates associated with rupture. 2, 5 Traditional treatment options include aneurysm exclusion, surgical excision or ligation, revascularization, and endovascular techniques such as angiographic embolization. 2, 4, 6 We report a case of a visceral pseudoaneurysm managed by EUS-guided thrombin injection and discuss the role of this novel technique.
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CASE REPORT
A 43-year-old man with chronic alcoholic pancreatitis was admitted with epigastric pain and hematemesis. The patient remained hemodynamically stable, although the hemoglobin count dropped to 9.5 g/dL. Upper GI endoscopy showed no blood in the stomach, and no esophageal or gastric varices or peptic ulcer disease was seen. Spiral CT demonstrated large dilated vessels around the stomach compatible with collateral vessel formation, pronounced inflammation around the pancreas, and a mass at the tail of the pancreas measuring 4 ϫ 3.2 cm with the appearance of a pseudoaneurysm of the splenic artery (Fig. 1) . Subsequently, a superselective angiogram was performed by using a C2 and Symmons type 1 catheter (Boston Scientific, Natick, Mass). The celiac trunk, splenic, hepatic, gastroduodenal, left and right gastric, and inferior and superior mesenteric arteries were visualized. The vascular stalk, however, could not be identified (Fig. 2) . Neither percutaneous nor surgical management was feasible because of large collateral vessels, the location of the pseudoaneurysm, and the recent attack of acute-on-chronic pancreatitis with subsequent inflammation and adhesions. EUSguided thrombin injection was selected because of the close proximity of the lesion to the gastric wall. The pseudoaneurysm, originating from the left gastric artery, was located by using a linear echoendoscope (Pentax Hitachi 7500; Pentax Hitachi, Montvale, NJ). A standard 22-gauge needle (Cook Endoscopy, Limerick, Ireland) was used to puncture the pseudoaneurysm, which was followed by injection of a total of 7 mL of a thrombin-collagen compound (D-stat; Vascular Solutions Inc, Minneapolis, MN). Color Doppler confirmed the complete obliteration of the lesion (Fig. 3) .
The patient recovered fully with complete resolution of all symptoms and was discharged within 24 hours. CT angiographies at 6 weeks and 10 months showed no recurrence of the pseudoaneurysm (Fig. 4) . The patient remains asymptomatic, without rebleeding, after 10 months in follow-up.
DISCUSSION
Patients with visceral pseudoaneurysms tend to present with abdominal pain and GI or intra-abdominal bleeding. Eighty-nine percent of patients are symptomatic, and 58% with bleeding are hemodynamically unstable at the time of presentation. 1 The initial diagnosis is commonly made by CT, although small visceral pseudoaneurysms may be missed. 2 Current treatment is by endovascular embolization, with surgery reserved for hemodynamically unstable patients. 2, 4, 6 Although angiographic embolization is less invasive than surgery, the mortality and complication rates 
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remain high. Rebleeding is especially common. 2, 4, 6 Difficulty in reaching and identifying the vascular stalk 2 and the need for general anesthesia in some patients make this technique suboptimal. EUS-guided thrombin injection bypasses these obstacles. Its close proximity to the lesion allows direct and precise injection of thrombin directly into the lesion. This affords an advantage over percutaneously administered thrombin where multiple layers need to be crossed. The procedure is minimally invasive, can be performed with the patient under conscious sedation, reduces procedure times, and has low complication and mortality rates, resulting in short hospital stays. Possible alternatives for thrombin that have been evaluated in endovascular settings include ethylene vinyl alcohol copolymer, 7 N-butyl-2-cyanoacrylate with or without coils, and endovascular coils alone. 2, 5 Ethylene vinyl alcohol copolymer mixed with micronized tantalum powder (Onyx) becomes radiopaque, allowing radiological imaging in addition to US, which may be of further benefit in the evaluation of distal escape.
A possible disadvantage of EUS is the complexity of the procedure. Complications when using endovascular techniques that may also apply to EUS therapy are rare but include distal embolisms and immunoreactions. 8 Distal escape when using EUS control can be prevented by carefully guided thrombin administration, and immunoreactions should be avoided by using autologous thrombin. 9 Recanalization after thrombin administered by endovascular techniques has been reported in the literature. In these reports recanalization could be successfully treated by a second thrombin administration. 10, 11 This makes careful follow-up mandatory. This is the third case report in which EUS-guided thrombin injection was successfully used in the management of a visceral pseudoaneurysm. 12, 13 Although limited data still exist, this novel technique is very promising as a first-line diagnostic and therapeutic tool in the management of visceral pseudoaneurysms. Further investigation to determine the usefulness and safety of this technique in open-label, single-arm study designs with safety monitoring or randomized pilot studies should be undertaken.
